CLINICAL_TRIALS
trial_result
· 2018-09-07
Clinical Trial Update: Long-term Observation PMS for Afatinib
Summary
Long-term observation study update for afatinib in non-small cell lung cancer has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED | Results posted: 2018-09-07